Patient-reported and morbidity-mortality endpoints: can one have the best of both worlds?

João Pedro Ferreira^{1

2}, Faiez Zannad¹

Affiliations

¹ Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
² Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Portugal.

Free article

Editorial

João Pedro Ferreira et al. Eur J Heart Fail. 2019 Jan.

Free article

. 2019 Jan;21(1):71-73.

doi: 10.1002/ejhf.1317. Epub 2018 Oct 2.

João Pedro Ferreira^{1

2}, Faiez Zannad¹

¹ Université de Lorraine, Inserm, Centre d'Investigations Cliniques-Plurithématique 14-33, and Inserm U1116, CHRU, F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists), Nancy, France.
² Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research and Development Unit, Faculty of Medicine, University of Porto, Portugal.

No abstract available

Comment on

Relationship between changing patient-reported outcomes and subsequent clinical events in patients with chronic heart failure: insights from HF-ACTION.
Luo N, O'Connor CM, Cooper LB, Sun JL, Coles A, Reed SD, Whellan DJ, Piña IL, Kraus WE, Mentz RJ. Luo N, et al. Eur J Heart Fail. 2019 Jan;21(1):63-70. doi: 10.1002/ejhf.1299. Epub 2018 Aug 31. Eur J Heart Fail. 2019. PMID: 30168635 Free PMC article. Clinical Trial.